Grandeur Peak Global Advisors’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-5,417
Closed -$1.5M 118
2020
Q3
$1.5M Sell
5,417
-8,958
-62% -$2.58M 0.1% 82
2020
Q2
$3.47M Sell
14,375
-7,475
-34% -$1.5M 0.27% 57
2020
Q1
$3.17M Sell
21,850
-35,314
-62% -$5.86M 0.34% 56
2019
Q4
$9.75M Buy
57,164
+11,175
+24% +$2.07M 0.91% 29
2019
Q3
$8.18M Buy
45,989
+43,414
+1,686% +$9.38M 0.89% 34
2019
Q2
$671K Buy
+2,575
New +$683K 0.07% 83
2015
Q1
Sell
-8,475
Closed -$323K 111
2014
Q4
$323K Sell
8,475
-159,875
-95% -$5.04M 0.07% 95
2014
Q3
$4.18M Sell
168,350
-208,600
-55% -$5.28M 1.02% 40
2014
Q2
$9.48M Buy
376,950
+75,300
+25% +$1.75M 2.04% 9
2014
Q1
$7.86M Buy
301,650
+28,800
+11% +$797K 1.85% 11
2013
Q4
$7.3M Buy
272,850
+87,800
+47% +$2.17M 1.94% 12
2013
Q3
$3.53M Buy
185,050
+52,750
+40% +$1.21M 0.98% 36
2013
Q2
$2.85M Buy
+132,300
New +$2.66M 1.1% 29

Other funds holding ABMD

Grandeur Peak Global Advisors's ABMD Position: Q4 2020 in Review

Grandeur Peak Global Advisors sold out of Abiomed Inc (ABMD) in Q4 2020, closing a stake of 5,417 shares — an estimated $1.5M sold.

Grandeur Peak Global Advisors first reported a position in ABMD in Q2 2013 and held it in 13 quarters. The position peaked at $9.75M in Q4 2019. 498 funds tracked by Wall St. Rank hold ABMD as of Q4 2020.

  • Grandeur Peak Global Advisors reported no remaining Abiomed Inc position as of Q4 2020 after selling out during the quarter.
  • Grandeur Peak Global Advisors sold 5,417 Abiomed Inc shares in Q4 2020, an estimated $1.5M.
  • Grandeur Peak Global Advisors first reported a position in Abiomed Inc in Q2 2013 and held it in 13 quarters.
  • Grandeur Peak Global Advisors's Abiomed Inc position peaked at $9.75M in Q4 2019.
  • 498 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2020.

Based on Grandeur Peak Global Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.